Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease

BACKGROUNDS: Optimal concentration of ustekinumab (UST) predicting endoscopic remission has not been fully investigated in Crohn’s disease (CD). We aimed to identify the optimal UST trough levels predicting clinical, laboratory and endoscopic remission in CD patients. METHODS: Twenty-eight patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayama, Hisashi, Morita, Yasuhiro, Imai, Takayuki, Takahashi, Kenichiro, Yoshida, Atsushi, Bamba, Shigeki, Inatomi, Osamu, Andoh, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027696/
https://www.ncbi.nlm.nih.gov/pubmed/35448957
http://dx.doi.org/10.1186/s12876-022-02271-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027696/
https://www.ncbi.nlm.nih.gov/pubmed/35448957
http://dx.doi.org/10.1186/s12876-022-02271-4

Ejemplares similares